Determine the necessary mass, volume, or concentration for preparing a solution.
NGM621 (anti-Complement C3) (Ab177907) - SEC
The purity of NGM621 (anti-Complement C3) (Ab177907) is more than 95% verified by HPLC.
NGM621 (anti-Complement C3) is an antibody targeting Complement C3. It binds with high affinity to intact human C3. It is used in the research for treatment of Geographic Atrophy.
NGM621 (anti-Complement C3) (Ab177907) - SEC
The purity of NGM621 (anti-Complement C3) (Ab177907) is more than 95% verified by HPLC.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Dec 16, 2025 | Ab177907 | |
| Certificate of Analysis | Dec 16, 2025 | Ab177907 | |
| Certificate of Analysis | Dec 16, 2025 | Ab177907 |
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
View Animal Free grade guide → View Carrier Free grade guide → View Recombinant grade guide → View Validated grade guide → View ExactAb™ grade guide → View Low Endotoxin grade guide → View Azide Free grade guide →